Am J Gastroenterol. 2008 Feb;103(2):383-5.

Magnesium: does a mineral prevent gallstones?

Abstract

Gallstone-related disorders are common and costly, but preventive measures are largely unexplored. Lifestyle risk factors include physical activity, obesity/overweight, and diet. Increasing consumption of magnesium appears to decrease the risk of symptomatic gallstones in men, although the underlying mechanisms remain unclear. Understanding the role of a healthy diet in gallstone-related diseases, including a diet high in magnesium, may lead to new preventive measures.

Comment on

Am J Gastroenterol. 2008 Feb;103(2):375-82.

PMID:: 18289201; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Magnesium

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

MAGNESIUM, ELEMENTAL - HSDB

Supplemental Content

Save items

Related citations in PubMed

Long-term effect of magnesium consumption on the risk of symptomatic gallstone disease among men. [Am J Gastroenterol. 2008]
Long-term effect of magnesium consumption on the risk of symptomatic gallstone disease among men.
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Am J Gastroenterol. 2008 Feb; 103(2):375-82. Epub 2007 Dec 12.
Review Energy balance, physical activity, and cancer risk. [Methods Mol Biol. 2009]
Review Energy balance, physical activity, and cancer risk.
Fair AM, Montgomery K. Methods Mol Biol. 2009; 472:57-88.
Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). [World J Gastroenterol. 2008]
Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project).
Festi D, Dormi A, Capodicasa S, Staniscia T, Attili AF, Loria P, Pazzi P, Mazzella G, Sama C, Roda E, et al. World J Gastroenterol. 2008 Sep 14; 14(34):5282-9.
Review Nutritional approaches to prevention and treatment of gallstones. [Altern Med Rev. 2009]
Review Nutritional approaches to prevention and treatment of gallstones.
Gaby AR. Altern Med Rev. 2009 Sep; 14(3):258-67.
Review The prevalence and risk factors for gallstone disease. [Clin Chem Lab Med. 2009]
Review The prevalence and risk factors for gallstone disease.
Yoo EH, Lee SY. Clin Chem Lab Med. 2009; 47(7):795-807.

See reviews... See all...

Cited by 1 PubMed Central article

Concept of the pathogenesis and treatment of cholelithiasis. [World J Hepatol. 2012]
Concept of the pathogenesis and treatment of cholelithiasis.
Reshetnyak VI. World J Hepatol. 2012 Feb 27; 4(2):18-34.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Magnesium: does a mineral prevent gallstones?
Magnesium: does a mineral prevent gallstones?
Am J Gastroenterol. 2008 Feb ;103(2):383-5.

PubMed
Monitoring and evaluation in flour fortification programs: design and implementa...
Monitoring and evaluation in flour fortification programs: design and implementation considerations.
Nutr Rev. 2008 Mar ;66(3):148-62.

PubMed
Mainstreaming nutrition into maternal and child health programmes: scaling up of...
Mainstreaming nutrition into maternal and child health programmes: scaling up of exclusive breastfeeding.
Matern Child Nutr. 2008 Apr ;4 Suppl 1:5-23.

PubMed
Antiviral treatment of HCV carriers with persistently normal ALT levels.
Antiviral treatment of HCV carriers with persistently normal ALT levels.
Mini Rev Med Chem. 2008 Feb ;8(2):150-2.

PubMed
Joint diseases and matrix metalloproteinases: a role for MMP-13.
Joint diseases and matrix metalloproteinases: a role for MMP-13.
Curr Pharm Biotechnol. 2008 Feb ;9(1):47-54.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: